Artificial intelligence (AI) holds great potential for medical progress, exemplified by UK startup Etcembly’s use of AI to develop a groundbreaking cancer immunotherapy, ETC-101. The study underscores the necessity for rigorous validation before deploying AI in clinical settings. Balancing AI’s potential for innovation with validation precautions is crucial for safe medical advancements.
Researchers Explore the Promise and Peril of Using AI to Fight Cancer
